STOCK TITAN

[Form 4] Alpha Teknova, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Alpha Teknova, Inc. (TKNO) – Form 4 insider filing dated 06/25/2025

The filing reports one transaction by Alexander Vos, a non-employee Director of Alpha Teknova. On 17 June 2025 Mr. Vos received 54,300 restricted stock units (RSUs) of common stock, coded “A” (award of securities). The RSUs were granted at a stated price of $0.00; they will vest in full on the first anniversary of the grant date (17 June 2026).

Following the award, Mr. Vos’ total reported beneficial ownership increased to 102,472 common shares, held directly. No derivative securities were involved and no shares were sold.

Implications for investors

  • The filing reflects equity-based compensation rather than an open-market purchase or sale, so cash did not change hands.
  • The incremental dilution from 54,300 shares is immaterial relative to Alpha Teknova’s outstanding share count (outstanding figure not provided in the filing).
  • The award lengthens the director’s equity exposure, which can better align board incentives with shareholder interests over the next 12 months.

Alpha Teknova, Inc. (TKNO) – Comunicazione interna Form 4 datata 25/06/2025

La comunicazione riporta una transazione effettuata da Alexander Vos, un Direttore non dipendente di Alpha Teknova. Il 17 giugno 2025 il Sig. Vos ha ricevuto 54.300 unità azionarie vincolate (RSU) di azioni ordinarie, codificate come “A” (assegnazione di titoli). Le RSU sono state concesse a un prezzo nominale di $0,00 e matureranno completamente al primo anniversario della data di assegnazione (17 giugno 2026).

Dopo l’assegnazione, la proprietà beneficiaria totale segnalata dal Sig. Vos è salita a 102.472 azioni ordinarie, detenute direttamente. Non sono stati coinvolti strumenti derivati e non sono state vendute azioni.

Implicazioni per gli investitori

  • La comunicazione riflette una compensazione basata su azioni e non un acquisto o vendita sul mercato aperto, quindi non c’è stato scambio di denaro.
  • La diluizione incrementale di 54.300 azioni è irrilevante rispetto al numero totale di azioni in circolazione di Alpha Teknova (numero non indicato nella comunicazione).
  • L’assegnazione estende l’esposizione azionaria del direttore, potendo allineare meglio gli incentivi del consiglio con gli interessi degli azionisti nei prossimi 12 mesi.

Alpha Teknova, Inc. (TKNO) – Presentación interna Formulario 4 fechada 25/06/2025

La presentación informa sobre una transacción realizada por Alexander Vos, un Director no empleado de Alpha Teknova. El 17 de junio de 2025, el Sr. Vos recibió 54,300 unidades restringidas de acciones (RSU) de acciones comunes, codificadas como “A” (adjudicación de valores). Las RSU fueron otorgadas a un precio declarado de $0.00 y se consolidarán por completo en el primer aniversario de la fecha de concesión (17 de junio de 2026).

Tras la adjudicación, la propiedad beneficiaria total reportada del Sr. Vos aumentó a 102,472 acciones comunes, mantenidas directamente. No se involucraron valores derivados ni se vendieron acciones.

Implicaciones para los inversores

  • La presentación refleja una compensación basada en acciones en lugar de una compra o venta en el mercado abierto, por lo que no hubo intercambio de efectivo.
  • La dilución incremental de 54,300 acciones es insignificante en relación con el número total de acciones en circulación de Alpha Teknova (cifra no proporcionada en la presentación).
  • La adjudicación extiende la exposición accionaria del director, lo que puede alinear mejor los incentivos del consejo con los intereses de los accionistas durante los próximos 12 meses.

Alpha Teknova, Inc. (TKNO) – 2025년 6월 25일자 내부자 신고서 Form 4

이 신고서는 Alpha Teknova의 비직원 이사Alexander Vos의 거래 한 건을 보고합니다. 2025년 6월 17일 Vos 씨는 보통주에 대한 54,300개의 제한 주식 단위(RSU)를 받았으며, 이는 “A” 코드(증권 수여)로 표시되어 있습니다. RSU는 명시된 가격 $0.00에 부여되었으며, 부여일로부터 1년째 되는 날(2026년 6월 17일)에 전액 베스팅됩니다.

수여 후 Vos 씨의 총 보고된 실소유 주식 수는 직접 보유 중인 102,472주로 증가했습니다. 파생상품은 포함되지 않았으며 주식 매도도 없었습니다.

투자자에게 미치는 영향

  • 이번 신고는 주식 기반 보상을 반영한 것으로, 공개 시장에서의 매매가 아니므로 현금 거래는 발생하지 않았습니다.
  • 54,300주의 추가 희석은 Alpha Teknova의 전체 발행 주식 수에 비해 미미한 수준입니다(발행 주식 수는 신고서에 기재되어 있지 않음).
  • 이번 수여는 이사의 지분 노출 기간을 연장하여, 향후 12개월 동안 이사회 인센티브와 주주 이익을 보다 잘 일치시킬 수 있습니다.

Alpha Teknova, Inc. (TKNO) – Déclaration d’initié Formulaire 4 datée du 25/06/2025

La déclaration rapporte une transaction réalisée par Alexander Vos, un directeur non salarié d’Alpha Teknova. Le 17 juin 2025, M. Vos a reçu 54 300 unités d’actions restreintes (RSU) d’actions ordinaires, codées « A » (attribution de titres). Les RSU ont été attribuées à un prix déclaré de 0,00 $ et seront entièrement acquises à la date du premier anniversaire de l’attribution (17 juin 2026).

Suite à cette attribution, la propriété bénéficiaire totale déclarée de M. Vos est passée à 102 472 actions ordinaires, détenues directement. Aucun titre dérivé n’a été impliqué et aucune action n’a été vendue.

Implications pour les investisseurs

  • La déclaration reflète une rémunération en actions plutôt qu’un achat ou une vente sur le marché ouvert, donc aucun échange d’argent n’a eu lieu.
  • La dilution supplémentaire de 54 300 actions est négligeable par rapport au nombre total d’actions en circulation d’Alpha Teknova (chiffre non fourni dans la déclaration).
  • L’attribution prolonge l’exposition en actions du directeur, ce qui peut mieux aligner les incitations du conseil d’administration avec les intérêts des actionnaires au cours des 12 prochains mois.

Alpha Teknova, Inc. (TKNO) – Insider-Meldung Form 4 vom 25.06.2025

Die Meldung berichtet über eine Transaktion von Alexander Vos, einem nicht angestellten Direktor von Alpha Teknova. Am 17. Juni 2025 erhielt Herr Vos 54.300 Restricted Stock Units (RSUs) von Stammaktien, codiert als „A“ (Zuteilung von Wertpapieren). Die RSUs wurden zu einem angegebenen Preis von 0,00 $ gewährt und werden am ersten Jahrestag des Zuteilungsdatums (17. Juni 2026) vollständig unverfallbar.

Nach der Zuteilung erhöhte sich der gemeldete wirtschaftliche Eigentum von Herrn Vos auf insgesamt 102.472 Stammaktien, die direkt gehalten werden. Es waren keine derivativen Wertpapiere beteiligt und es wurden keine Aktien verkauft.

Auswirkungen für Investoren

  • Die Meldung spiegelt eine aktienbasierte Vergütung wider und keinen Kauf oder Verkauf auf dem offenen Markt, daher floss kein Geld.
  • Die zusätzliche Verwässerung durch 54.300 Aktien ist unwesentlich im Verhältnis zur ausstehenden Aktienanzahl von Alpha Teknova (ausstehende Anzahl nicht in der Meldung angegeben).
  • Die Zuteilung verlängert die Aktienexponierung des Direktors, was die Ausgerichtetheit der Vorstandsinteressen mit denen der Aktionäre in den nächsten 12 Monaten verbessern kann.
Positive
  • No insider selling; transaction is an equity award, which avoids negative signal of stock disposal.
  • Increased insider ownership may better align director incentives with shareholder interests.
Negative
  • Minor share dilution from issuance of 54,300 new shares, though impact is likely immaterial.

Insights

TL;DR: Director received 54k RSUs; no shares sold, neutral capital-market signal.

The Form 4 shows a standard annual equity grant. Because the award was made at $0 and vests after one year, it functions as compensation rather than a directional bet. No market purchase or sale occurred, so there is no immediate trading signal. The additional 54,300 shares represent a very small fraction of Teknova’s float and therefore minimal dilution. From a governance standpoint, the filing is slightly positive as it increases insider ownership, but the effect on valuation or liquidity is negligible.

TL;DR: Routine RSU grant enhances alignment, limited corporate impact.

Board-level equity grants are common for life-science tools companies such as Teknova. A one-year cliff vest aligns decision-making over the short term without locking the director in for multiple years. There are no red-flags such as accelerated vesting or large option packages. Overall, the filing is a normal compensation event that mildly strengthens incentive alignment while having no material governance concerns.

Alpha Teknova, Inc. (TKNO) – Comunicazione interna Form 4 datata 25/06/2025

La comunicazione riporta una transazione effettuata da Alexander Vos, un Direttore non dipendente di Alpha Teknova. Il 17 giugno 2025 il Sig. Vos ha ricevuto 54.300 unità azionarie vincolate (RSU) di azioni ordinarie, codificate come “A” (assegnazione di titoli). Le RSU sono state concesse a un prezzo nominale di $0,00 e matureranno completamente al primo anniversario della data di assegnazione (17 giugno 2026).

Dopo l’assegnazione, la proprietà beneficiaria totale segnalata dal Sig. Vos è salita a 102.472 azioni ordinarie, detenute direttamente. Non sono stati coinvolti strumenti derivati e non sono state vendute azioni.

Implicazioni per gli investitori

  • La comunicazione riflette una compensazione basata su azioni e non un acquisto o vendita sul mercato aperto, quindi non c’è stato scambio di denaro.
  • La diluizione incrementale di 54.300 azioni è irrilevante rispetto al numero totale di azioni in circolazione di Alpha Teknova (numero non indicato nella comunicazione).
  • L’assegnazione estende l’esposizione azionaria del direttore, potendo allineare meglio gli incentivi del consiglio con gli interessi degli azionisti nei prossimi 12 mesi.

Alpha Teknova, Inc. (TKNO) – Presentación interna Formulario 4 fechada 25/06/2025

La presentación informa sobre una transacción realizada por Alexander Vos, un Director no empleado de Alpha Teknova. El 17 de junio de 2025, el Sr. Vos recibió 54,300 unidades restringidas de acciones (RSU) de acciones comunes, codificadas como “A” (adjudicación de valores). Las RSU fueron otorgadas a un precio declarado de $0.00 y se consolidarán por completo en el primer aniversario de la fecha de concesión (17 de junio de 2026).

Tras la adjudicación, la propiedad beneficiaria total reportada del Sr. Vos aumentó a 102,472 acciones comunes, mantenidas directamente. No se involucraron valores derivados ni se vendieron acciones.

Implicaciones para los inversores

  • La presentación refleja una compensación basada en acciones en lugar de una compra o venta en el mercado abierto, por lo que no hubo intercambio de efectivo.
  • La dilución incremental de 54,300 acciones es insignificante en relación con el número total de acciones en circulación de Alpha Teknova (cifra no proporcionada en la presentación).
  • La adjudicación extiende la exposición accionaria del director, lo que puede alinear mejor los incentivos del consejo con los intereses de los accionistas durante los próximos 12 meses.

Alpha Teknova, Inc. (TKNO) – 2025년 6월 25일자 내부자 신고서 Form 4

이 신고서는 Alpha Teknova의 비직원 이사Alexander Vos의 거래 한 건을 보고합니다. 2025년 6월 17일 Vos 씨는 보통주에 대한 54,300개의 제한 주식 단위(RSU)를 받았으며, 이는 “A” 코드(증권 수여)로 표시되어 있습니다. RSU는 명시된 가격 $0.00에 부여되었으며, 부여일로부터 1년째 되는 날(2026년 6월 17일)에 전액 베스팅됩니다.

수여 후 Vos 씨의 총 보고된 실소유 주식 수는 직접 보유 중인 102,472주로 증가했습니다. 파생상품은 포함되지 않았으며 주식 매도도 없었습니다.

투자자에게 미치는 영향

  • 이번 신고는 주식 기반 보상을 반영한 것으로, 공개 시장에서의 매매가 아니므로 현금 거래는 발생하지 않았습니다.
  • 54,300주의 추가 희석은 Alpha Teknova의 전체 발행 주식 수에 비해 미미한 수준입니다(발행 주식 수는 신고서에 기재되어 있지 않음).
  • 이번 수여는 이사의 지분 노출 기간을 연장하여, 향후 12개월 동안 이사회 인센티브와 주주 이익을 보다 잘 일치시킬 수 있습니다.

Alpha Teknova, Inc. (TKNO) – Déclaration d’initié Formulaire 4 datée du 25/06/2025

La déclaration rapporte une transaction réalisée par Alexander Vos, un directeur non salarié d’Alpha Teknova. Le 17 juin 2025, M. Vos a reçu 54 300 unités d’actions restreintes (RSU) d’actions ordinaires, codées « A » (attribution de titres). Les RSU ont été attribuées à un prix déclaré de 0,00 $ et seront entièrement acquises à la date du premier anniversaire de l’attribution (17 juin 2026).

Suite à cette attribution, la propriété bénéficiaire totale déclarée de M. Vos est passée à 102 472 actions ordinaires, détenues directement. Aucun titre dérivé n’a été impliqué et aucune action n’a été vendue.

Implications pour les investisseurs

  • La déclaration reflète une rémunération en actions plutôt qu’un achat ou une vente sur le marché ouvert, donc aucun échange d’argent n’a eu lieu.
  • La dilution supplémentaire de 54 300 actions est négligeable par rapport au nombre total d’actions en circulation d’Alpha Teknova (chiffre non fourni dans la déclaration).
  • L’attribution prolonge l’exposition en actions du directeur, ce qui peut mieux aligner les incitations du conseil d’administration avec les intérêts des actionnaires au cours des 12 prochains mois.

Alpha Teknova, Inc. (TKNO) – Insider-Meldung Form 4 vom 25.06.2025

Die Meldung berichtet über eine Transaktion von Alexander Vos, einem nicht angestellten Direktor von Alpha Teknova. Am 17. Juni 2025 erhielt Herr Vos 54.300 Restricted Stock Units (RSUs) von Stammaktien, codiert als „A“ (Zuteilung von Wertpapieren). Die RSUs wurden zu einem angegebenen Preis von 0,00 $ gewährt und werden am ersten Jahrestag des Zuteilungsdatums (17. Juni 2026) vollständig unverfallbar.

Nach der Zuteilung erhöhte sich der gemeldete wirtschaftliche Eigentum von Herrn Vos auf insgesamt 102.472 Stammaktien, die direkt gehalten werden. Es waren keine derivativen Wertpapiere beteiligt und es wurden keine Aktien verkauft.

Auswirkungen für Investoren

  • Die Meldung spiegelt eine aktienbasierte Vergütung wider und keinen Kauf oder Verkauf auf dem offenen Markt, daher floss kein Geld.
  • Die zusätzliche Verwässerung durch 54.300 Aktien ist unwesentlich im Verhältnis zur ausstehenden Aktienanzahl von Alpha Teknova (ausstehende Anzahl nicht in der Meldung angegeben).
  • Die Zuteilung verlängert die Aktienexponierung des Direktors, was die Ausgerichtetheit der Vorstandsinteressen mit denen der Aktionäre in den nächsten 12 Monaten verbessern kann.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vos Alexander

(Last) (First) (Middle)
C/O ALPHA TEKNOVA, INC.
2451 BERT DRIVE

(Street)
HOLLISTER CA 95023

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alpha Teknova, Inc. [ TKNO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A 54,300(1) A $0.0 102,472 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted on June 17, 2025. Shares subject to the award vest on the first anniversary of the grant date.
By: Damon A. Terrill For: Alexander Vos 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alexander Vos report in the TKNO Form 4?

An award of 54,300 restricted stock units granted on 06/17/2025.

Did the insider sell any Alpha Teknova shares?

No; the filing shows only an acquisition (award) and zero shares sold.

How many TKNO shares does Alexander Vos own after the transaction?

He now beneficially owns 102,472 common shares.

When will the newly granted RSUs vest?

They vest on 17 June 2026, one year after the grant date.

Is the transaction under a Rule 10b5-1 trading plan?

The filing does not indicate that the award is tied to a 10b5-1 plan.
Alpha Teknova

NASDAQ:TKNO

TKNO Rankings

TKNO Latest News

TKNO Latest SEC Filings

TKNO Stock Data

282.17M
9.85M
9.28%
82.67%
3.11%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
HOLLISTER